All Federal

Published between:
Published Title Organization
Sep
21
2023
DELETE IT!: Fluent Just Asked Everyone Who Bought Consumer Data From It Prior to May, 2023 to Delete It And This Is Where We Are Now Troutman Amin, LLP
Sep
21
2023
Work-Out or Walk-Out: The Difficult Decision Facing Commercial Office Owners ArentFox Schiff LLP
Sep
21
2023
Blockchain+ Bi-Weekly - September 21, 2023 Polsinelli PC
Sep
21
2023
Self-Directed IRAs and the Prohibited Transaction Rules – Part 2 ArentFox Schiff LLP
Sep
21
2023
Copyright Office Seeks Comments on Artificial Intelligence McDermott Will & Schulte LLP
Sep
21
2023
Penalty Offense Authority and the Future of FTC Privacy Law ArentFox Schiff LLP
Sep
21
2023
Code § 4980D and Violations of the NQTL Analysis Requirement Under the Proposed MHPAEA Regulations McDermott Will & Schulte LLP
Sep
21
2023
Teaming Up? EEOC and DOL Announce Enhanced Enforcement Efforts Bradley Arant Boult Cummings LLP
Sep
21
2023
Mastering the CRM Marathon: Actionable Steps to Continuous Growth and Success CLIENTSFirst Consulting
Sep
21
2023
How Alcohol Industry Members Can Prepare for a Government Shutdown McDermott Will & Schulte LLP
Sep
21
2023
How to Harness the Power of eCards for Client Outreach This Holiday Season CLIENTSFirst Consulting
Sep
20
2023
How to Successfully Navigate the Best Lawyers Rankings Process Stefanie Marrone Consulting
Sep
20
2023
IRS Halts Processing of Employee Retention Credit Claims, Announces Initiatives for ERC Claims Filed by Ineligible Businesses Greenberg Traurig, LLP
Sep
20
2023
October 2023 Visa Bulletin Released With an Estimated 165,000 Employment-Based Visa Numbers for FY 2024 Available Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Sep
20
2023
Diving Into SECURE 2.0: New DOL Lost and Found, Updates to EPCRS, and Delayed Implementation of Roth Catch-Up Requirement Foley & Lardner LLP
Sep
20
2023
Leveraging LinkedIn for Lawyers: How to Turn Connections to Clients Stefanie Marrone Consulting
Sep
20
2023
Antitrust and AI: US Antitrust Regulators Increasingly Focused on the Potential Anticompetitive Effects of AI K&L Gates LLP
Sep
20
2023
New Record for Number of Employees Affected by Rule 21F-17(a) Violations Does Not Lead to Increase in Sanctions Against CBRE Kohn, Kohn & Colapinto
Sep
20
2023
And The Crowd Goes Wild: IRS Delays SECURE 2.0 Roth Catch-Up Rule Until 2026 Foley & Lardner LLP
Sep
20
2023
Mintz IRA Update — The First Anniversary of the Inflation Reduction Act: A Year in Review Mintz
Sep
20
2023
Action Steps Health Plans Should Take Now In Response To New DOL Guidance on Mental Health Parity Foley & Lardner LLP
Sep
20
2023
Four Ways to Effectively Align Your CRM with Attorney Needs CLIENTSFirst Consulting
Sep
20
2023
Mastering CRM Metrics: Strategies for Measurable Success CLIENTSFirst Consulting
Sep
20
2023
The Role of Tax Incentives in Driving Carbon Capture and Environmental Compliance [Podcast] Bracewell LLP
Sep
20
2023
15 Minutes on Congress: Appropriations Edition Part 2 [Podcast] ArentFox Schiff LLP
Sep
20
2023
Lack of Consensus, Lapse in Appropriations: Anatomy of a Federal Government Shutdown Squire Patton Boggs (US) LLP
Sep
20
2023
Executive Compensation Clawback Policies: Now Is the Time to Consider Insurance Hunton Andrews Kurth
Sep
20
2023
Navigating 2023’s Employment Landscape: Legal Compliance and the Perils of Template Reuse Stark & Stark
Sep
20
2023
Avoiding Collateral Damage: Whose Pledged Assets Are They Anyways? ArentFox Schiff LLP
Sep
20
2023
FDA Provides Update on the Cronobacter Prevention Strategy in Powdered Infant Formula Keller and Heckman LLP
Sep
20
2023
Introduction: Impacts of a Government Shutdown K&L Gates LLP
Sep
20
2023
Mintz IRA Update — Other Key IRA Programs and Developments: The Medicare Prescription Drug Inflation Rebate Program and Maximum Monthly Cap on Cost-Sharing Payments Program Mintz
Sep
20
2023
EPA Announces Its Final National Enforcement and Compliance Initiatives Greenberg Traurig, LLP
Sep
20
2023
US Copyright Office Seeks Comments Concerning AI ArentFox Schiff LLP
Sep
20
2023
There’s One for You, Nineteen for Me: IRS Issues Guidance on 1900% Pharmaceutical Excise Tax ArentFox Schiff LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters